Mobile

A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate to...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000414-39

A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate to severe osteoarthritis pain of the hip and/or knee

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate to severe osteoarthritis pain of the hip and/or knee.

Critère d'inclusion

  • Chronic, moderate to severe osteoarthritis pain of the hip and/or knee

Liens